» Articles » PMID: 29131706

Alzheimer's Disease-Current Status and Future Directions

Overview
Journal J Med Food
Date 2017 Nov 14
PMID 29131706
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder of the brain. The presence of amyloid-beta (Aβ) plaques, neurofibrillary tangles (NFTs), loss of neurons, synapses, and altered sensory perceptions, including memory loss, delineate AD. However, the cause of AD is not clearly known. Several genetic and nongenetic factors have been implicated in the disease. Of the genes, the ɛ4 allele of apolipoprotein E is the largest known genetic risk factor of AD. This review article focuses on the various genetic and other predisposing factors that account for AD, pathophysiology of the disease, and the mechanisms by which Aβ plaques and NFTs are formed and could affect AD brain. In addition, recent advances and current diagnostics available for AD patients are detailed. As oxidative stress has been implicated in the etiology of the disease, special emphasis is given for nutrition based antioxidant therapies and interventional strategies for reducing/treating AD.

Citing Articles

Application of the Trend of miRNA Expression Levels in APP/PS1 Mice Plasma for the Early Diagnosis of Alzheimer's Disease.

Zhang Y, Wang Y, Zhao F Mol Neurobiol. 2025; .

PMID: 39937416 DOI: 10.1007/s12035-025-04743-6.


Study of the multitarget mechanism of (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking technology.

Lv F, Sun M, Qin C, Du D, Zheng X, Li W Pharm Biol. 2024; 62(1):634-647.

PMID: 39066667 PMC: 11285284. DOI: 10.1080/13880209.2024.2382962.


Hemispheric Patterns of Recruitment of Object Processing Regions in Early Alzheimer's Disease: A Study Along the Entire Ventral Stream.

Canario N, Jorge L, Santana I, Castelo-Branco M J Alzheimers Dis. 2022; 91(3):1151-1164.

PMID: 36565110 PMC: 9912740. DOI: 10.3233/JAD-220055.


Exploring the Mechanism of Saponins against Alzheimer's Disease by Network Pharmacology and Experimental Validation.

Jiang Y, Li S, Xie X, Li H, Huang P, Li B Evid Based Complement Alternat Med. 2022; 2021:5730812.

PMID: 35003304 PMC: 8739172. DOI: 10.1155/2021/5730812.


Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population.

Ben Salem N, Boussetta S, de Rojas I, Moreno-Grau S, Montrreal L, Mokni N Mol Biol Rep. 2021; 49(3):1687-1700.

PMID: 34854014 DOI: 10.1007/s11033-021-06978-7.